Underreporting of minor transfusion reactions in cancer patients.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 1395759)

Published in MedGenMed on May 19, 2004

Authors

Aida B Narvios1, Benjamin Lichtiger, Joyce L Neumann

Author Affiliations

1: University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.

Articles by these authors

Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study. Lancet (2002) 2.10

Cytomegalovirus infection in cancer patients receiving granulocyte transfusions. Blood (2002) 1.49

Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections. Surgery (2009) 1.18

Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections. Cancer (2004) 1.16

Targeting neuropilin-1 in human leukemia and lymphoma. Blood (2010) 1.03

Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions. Cancer (2006) 0.97

Detection and control of a nosocomial respiratory syncytial virus outbreak in a stem cell transplantation unit: the role of palivizumab. Biol Blood Marrow Transplant (2010) 0.97

Designing an ethical policy for bone marrow donation by minors and others lacking capacity. Camb Q Healthc Ethics (2004) 0.96

Estimating mutant microsatellite allele frequencies in somatic cells by small-pool PCR. Genomics (2004) 0.91

Transjugular liver biopsy in patients with hematologic malignancy and severe thrombocytopenia. J Vasc Interv Radiol (2003) 0.86

Detecting bacteria in platelet concentrates by use of reagent strips. Transfusion (2002) 0.86

Method of removing incompatible red blood cells from granulocyte components. Transfus Apher Sci (2006) 0.82

Impact of safety concerns and regulatory changes on the usage of erythropoiesis-stimulating agents and RBC transfusions. Oncologist (2010) 0.81

Impact on patient outcome following transfusion of bacterially contaminated platelets: the M.D. Anderson Cancer Center experience. Am J Clin Pathol (2010) 0.80

Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients. MedGenMed (2004) 0.80

In vivo efficacy of shipped HLA-matched platelets. Transfusion (2006) 0.79

Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphoma. Leuk Lymphoma (2002) 0.79

Slow infusion of platelets: a possible alternative in the management of refractory thrombocytopenic patients. Am J Hematol (2005) 0.79

Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation. Br J Haematol (2013) 0.78

Design, development, and validation of a high-throughput drug-screening assay for targeting of human leukemia. Cancer (2013) 0.75

Reagent strips may not detect Staphylococcus epidermidis contamination of platelet concentrates. Arch Pathol Lab Med (2004) 0.75

Granulocyte concentrates from a single high-yield apheresis can be split to support multiple patients. Leuk Lymphoma (2014) 0.75

Results of HLA antibody testing using ELISA vs the fluorescent bead method and retrospective review of data for recipients of packed RBCs and platelets from male HLA-immunized donors. Am J Clin Pathol (2011) 0.75

Intraarterial platelet infusion for patients with intractable gastrointestinal hemorrhage and severe refractory thrombocytopenia. J Vasc Interv Radiol (2004) 0.75

Acceptability of isosulfan blue dye-contaminated blood samples in blood typing and antibody screening laboratory testing in a cancer center. Transfusion (2010) 0.75

Prevalence of hepatitis C in a drug using and non-using welfare population. Health Policy (2003) 0.75

Thirty-day typing and screening for patients undergoing elective surgery: experience at a large cancer center. Transfusion (2006) 0.75

Septic transfusion reactions during blood transfusion via indwelling central venous catheters. Transfusion (2014) 0.75